| clinical trial | Q30612 |
| P3098 | ClinicalTrials.gov ID | NCT00567606 |
| P6099 | clinical trial phase | phase IV clinical trial | Q42825046 |
| P17 | country | United States of America | Q30 |
| P4135 | maximum age | 75 | |
| P1050 | medical condition | osteoporosis | Q165328 |
| P2899 | minimum age | 35 | |
| P1132 | number of participants | 249 | |
| P4844 | research intervention | (5R)-24,25-Dihydroxyvitamin D | Q27161510 |
| risedronic acid | Q408724 | ||
| calcium oxalate | Q412399 | ||
| P859 | sponsor | University of Nebraska–Lincoln | Q1353679 |
| P580 | start time | 2002-04-01 | |
| P8363 | study type | interventional study | Q78089383 |
| P1476 | title | Prevention of Osteoporosis in Breast Cancer Survivors |
Search more.